Lecture 25 Insulin Dependent Diabetes Mellitus Type 1 Diabetes Juvenile Onset Diabetes
Download ReportTranscript Lecture 25 Insulin Dependent Diabetes Mellitus Type 1 Diabetes Juvenile Onset Diabetes
Lecture 25 Insulin Dependent Diabetes Mellitus Type 1 Diabetes Juvenile Onset Diabetes 500 BC • • • • • Frequent urination Rapid loss of weight Unquenchable thirst “Sweet” breath Death within a few weeks – Diabetes • Urine contains sugar – Mellitus Hypoinsulinemia • Think about what insulin does – Not just anabolic, also anti-catabolic • Prevents – Glycogenolysis – Proteolysis – Lipolysis • Stimulates – Glucose uptake and disposal Lack of Insulin • Poor glucose uptake into cells – But not zero, and only muscle/WAT affected – Will elicit a bit of hyperglycemia • Poor lipogenesis & glycogenesis – Of little consequence • Massive, uncontrolled lipolysis – Huge release of fatty acids into the bloodstream • And glycerol – High rates of fatty acid oxidation • Inhibits glucose oxidation, glucose lactate – High rates of ketone body production • Inhibts glucose metabolism in the brain • Uncontrolled proteolysis – Breakdown of tissues – Release of amino acids into bloodstream Lipolysis & Proteolysis • Weight loss – Dangerous loss of essential protein • Increasing hyperglycemia – High rates of gluconeogenesis • Glycerol, amino acids & lactate as substrates • Fatty acid oxidation stimulating pyruvate carboxylase • Low insulin, increased cAMP increased F16BPase – Low rates of glucose disposal • Blood acidity rises – Fatty acids, lactate, ketone bodies all acidic – Ketoacidosis • Ketone bodies decarboxylate – Acetone lost on breath Hyperglycemia • Glycosylation increases – But long term • Loss of glucose in urine – Glucose reabsorbtion by kidneys reduced above [glucose]blood =10 mM • Osmolality of blood changes – Draws water out of the tissues – Massive thrist • Increased water intake – Increased urination – Loss of electrolytes Treatment • Insulin – Discovered & first used in 1922 • Tight control to avoid complications – Blood glucose monitoring – Tailored insulin injections • Long and short acting forms – Risk of hypoglycemia • Hypoglycemia unawareness